-+ 0.00%
-+ 0.00%
-+ 0.00%
Hansa Biopharma names Adam Cutler CFO, effective June 22
Share
Listen to the news
Hansa Biopharma names Adam Cutler CFO, effective June 22
  • Hansa Biopharma named Adam Cutler CFO, effective June 22, 2026.
  • Cutler joins from Mural Oncology; previously CFO at Q32 Bio, Molecular Templates.
  • Evan Ballantyne, CFO since 2024, steps down June 22; remains until July 10 to support the transition.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansa Biopharma AB published the original content used to generate this news brief on June 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending